(Q42208682)

18 October 2017

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors (English)

1 reference

18 October 2017

M A Critchley

1

1 reference

PubMed ID

3124184

18 October 2017

S L Handley

series ordinal

2

1 reference

18 October 2017

1 January 1987

1 reference

18 October 2017

1 reference

18 October 2017

93

1 reference

18 October 2017

4

1 reference

18 October 2017

502-506

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00207243

18 October 2017

0 references

cites work

Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat

1 reference

12 December 2020

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

1 reference

12 December 2020

Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

1 reference

12 December 2020

Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

12 December 2020

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1 reference

12 December 2020

The relation between fear induced by novel stimulation and exploratory behavior.

1 reference

12 December 2020

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

12 December 2020

Recent developments in 5HT-related pharmacology of animal models of anxiety.

1 reference

12 December 2020

Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain

1 reference

12 December 2020

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

1 reference

12 December 2020

5-HT and anxiety: promises and pitfalls

1 reference

12 December 2020

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

12 December 2020

Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?

1 reference

12 December 2020

Drug interactions do not support reduction in serotonin turnover as the mechanism of action of benzodiazepines

1 reference

12 December 2020

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

1 reference

12 December 2020

Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

1 reference

12 December 2020

Pharmacology of potent and selective S2-serotonergic antagonists

1 reference

12 December 2020

Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.

1 reference

12 December 2020

Serotonergic neurons and behavior

1 reference

12 December 2020

Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00207243

1 reference

PubMed ID

3124184

Dimensions Publication ID

18 October 2017

0 references

1 reference

PubMed ID

3124184